A COVID-19 peptide vaccine for the induction of SARS-CoV-2 T cell immunity

T cell immunity is central for the control of viral infections. CoVac-1 is a peptide-based vaccine candidate, composed of SARS-CoV-2 T cell epitopes derived from various viral proteins(1,2), combined with the Toll-like receptor 1/2 agonist XS15 emulsified in Montanide ISA51 VG, aiming to induce prof...

Descripción completa

Detalles Bibliográficos
Autores principales: Heitmann, Jonas S., Bilich, Tatjana, Tandler, Claudia, Nelde, Annika, Maringer, Yacine, Marconato, Maddalena, Reusch, Julia, Jäger, Simon, Denk, Monika, Richter, Marion, Anton, Leonard, Weber, Lisa Marie, Roerden, Malte, Bauer, Jens, Rieth, Jonas, Wacker, Marcel, Hörber, Sebastian, Peter, Andreas, Meisner, Christoph, Fischer, Imma, Löffler, Markus W., Karbach, Julia, Jäger, Elke, Klein, Reinhild, Rammensee, Hans-Georg, Salih, Helmut R., Walz, Juliane S.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8791831/
https://www.ncbi.nlm.nih.gov/pubmed/34814158
http://dx.doi.org/10.1038/s41586-021-04232-5

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8791831/
https://www.ncbi.nlm.nih.gov/pubmed/34814158
http://dx.doi.org/10.1038/s41586-021-04232-5

Ejemplares similares